Literature DB >> 1894381

Recombinant human tumor necrosis factor alpha promotes adherence of Staphylococcus aureus to cultured human endothelial cells.

A L Cheung1, J M Koomey, S Lee, E A Jaffe, V A Fischetti.   

Abstract

Tumor necrosis factor (TNF), a potent inflammatory mediator secreted by monocytes during inflammation, was shown to significantly increase the adherence of Staphylococcus aureus to cultured human umbilical vein endothelial cells in vitro. The stimulatory effect of TNF was dose dependent and was bimodal with respect to time; bacterial adhesion peaked after 4 and 16 h of stimulation with recombinant human TNF-alpha. The ability of TNF-alpha to augment staphylococcal adherence to endothelial cells was contingent upon the presence of plasma factors. Thus, the complex interaction among cytokines (such as TNF), plasma factor(s), and the endothelium serves to modulate bacterial adherence to endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1894381      PMCID: PMC258959          DOI: 10.1128/iai.59.10.3827-3831.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Identification of an inducible endothelial-leukocyte adhesion molecule.

Authors:  M P Bevilacqua; J S Pober; D L Mendrick; R S Cotran; M A Gimbrone
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

2.  Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon.

Authors:  J S Pober; M A Gimbrone; L A Lapierre; D L Mendrick; W Fiers; R Rothlein; T A Springer
Journal:  J Immunol       Date:  1986-09-15       Impact factor: 5.422

Review 3.  The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response.

Authors:  J W Larrick; S L Kunkel
Journal:  Pharm Res       Date:  1988-03       Impact factor: 4.200

4.  Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers.

Authors:  A H Stolpen; E C Guinan; W Fiers; J S Pober
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

Review 5.  Effects of tumour necrosis factor and related cytokines on vascular endothelial cells.

Authors:  J S Pober
Journal:  Ciba Found Symp       Date:  1987

6.  Human endothelial cell response to lipopolysaccharide, interleukin-1, and tumor necrosis factor is regulated by protein synthesis.

Authors:  T H Pohlman; J M Harlan
Journal:  Cell Immunol       Date:  1989-03       Impact factor: 4.868

7.  Fibrinogen acts as a bridging molecule in the adherence of Staphylococcus aureus to cultured human endothelial cells.

Authors:  A L Cheung; M Krishnan; E A Jaffe; V A Fischetti
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

8.  Cultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin 1, endotoxin, and tumor-promoting phorbol diesters.

Authors:  R P Schleimer; B K Rutledge
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

9.  Variation in the expression of cell wall proteins of Staphylococcus aureus grown on solid and liquid media.

Authors:  A L Cheung; V A Fischetti
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

10.  Bacterial adherence to human endothelial cells.

Authors:  P D Thomas; F W Hampson; G W Hunninghake
Journal:  J Appl Physiol (1985)       Date:  1988-09
View more
  12 in total

1.  Staphylococcus aureus adherence to nasal epithelial cells in a physiological in vitro model.

Authors:  A Hoefnagels-Schuermans; W E Peetermans; M Jorissen; S Van Lierde; J van den Oord; R De Vos; J Van Eldere
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-09       Impact factor: 2.416

2.  Shear stress prevents fibronectin binding protein-mediated Staphylococcus aureus adhesion to resting endothelial cells.

Authors:  K Reddy; J M Ross
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

3.  Histopathological and serological progression of experimental Staphylococcus aureus arthritis.

Authors:  T Bremell; A Abdelnour; A Tarkowski
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

4.  Preinfection systemic inflammatory markers and risk of hospitalization due to pneumonia.

Authors:  Sachin Yende; Elaine I Tuomanen; Richard Wunderink; Alka Kanaya; Anne B Newman; Tamara Harris; Nathalie de Rekeneire; Stephen B Kritchevsky
Journal:  Am J Respir Crit Care Med       Date:  2005-09-15       Impact factor: 21.405

5.  Role of the sar locus of Staphylococcus aureus in induction of endocarditis in rabbits.

Authors:  A L Cheung; M R Yeaman; P M Sullam; M D Witt; A S Bayer
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

6.  Gamma interferon confers resistance to infection with Staphylococcus aureus in human vascular endothelial cells by cooperative proinflammatory and enhanced intrinsic antibacterial activities.

Authors:  Henry Beekhuizen; Joke S van de Gevel
Journal:  Infect Immun       Date:  2007-09-24       Impact factor: 3.441

7.  The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model.

Authors:  A Abdelnour; S Arvidson; T Bremell; C Rydén; A Tarkowski
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

8.  Cloning, expression, and nucleotide sequence of a Staphylococcus aureus gene (fbpA) encoding a fibrinogen-binding protein.

Authors:  A I Cheung; S J Projan; R E Edelstein; V A Fischetti
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

9.  Adherence of Haemophilus somnus to tumor necrosis factor-alpha-stimulated bovine endothelial cells in culture.

Authors:  J M Kwiecien; P B Little; M A Hayes
Journal:  Can J Vet Res       Date:  1994-07       Impact factor: 1.310

10.  Staphylococcus aureus extracellular adherence protein triggers TNFα release, promoting attachment to endothelial cells via protein A.

Authors:  Andrew M Edwards; Maria Gabriela Bowden; Eric L Brown; Maisem Laabei; Ruth C Massey
Journal:  PLoS One       Date:  2012-08-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.